Textbook outcomes in liver surgery: A decade of experience at a cancer-dedicated centre. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full ...
Phase 1 trial of navitoclax and sorafenib in patients with refractory solid tumors with a hepatocellular carcinoma expansion cohort. Impact of baseline liver function on survival outcomes in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results